AzTrials
AzTrials

Depression MildNCT06072209

Long-term Effects ReSet Your Mind - Mechanisms

A study testing Behavioral Activation, Mindfulness and Gratitude and Combination of Behavioral Activation and Mindfulness and Gratitude in people with Depression Mild and Depression Moderate, run by Philipps University Marburg at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

See: ClinicalTrials.gov ID: NCT05402150 Relevant for this Paper: This investigation aims to evaluate the stability of the effectiveness of different two-week online interventions in a four months follow-up regarding reward sensitivity, anhedonia and depression. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Depression Mild, Depression Moderate
What is being tested?
Behavioral Activation, Mindfulness and Gratitude and Combination of Behavioral Activation and Mindfulness and Gratitude
Could I receive a placebo?
No, everyone receives an active treatment
How many people
224 participants
Where
1 siteGermany
Study dates
30 May 2022to 15 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 or above
  • Fluent in German
  • Informed consent
  • Depressive symptoms (PHQ-9 > 5)

Who cannot join

  • suicidality, severe depression
  • current or lifetime: substance use disorder, psychotic disorders, bipolar I or II
  • current psychotherapy
  • if antidepressant medication: has not been stable over the last 4 weeks

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Philipps University

    Marburg, 35037

Other trials in Germany

About this study

Official title: Long-term Effects of an Online Intervention Targeting Depression and Reward Sensitivity - Predictors and Mechanisms of Treatment Success

See: ClinicalTrials.gov ID: NCT05402150

Relevant for this Paper:

Read more

This investigation aims to evaluate the stability of the effectiveness of different two-week online interventions in a four months follow-up regarding reward sensitivity, anhedonia and depression.

The authors will further investigate factors influencing treatment success regarding reward sensitivity. The investigators assume that the more depressive expectations and stress improve during our online intervention, the more change in reward insensitivity is experienced at follow-up. In addition, it is hypothesized that the more people engaged in physical activities and social encounters during the two-week online intervention, the more change in reward insensitivity is experienced at follow-up.

Read the detailed description

See for main study: ClinicalTrials.gov ID: NCT05402150.

A possible maintaining role in depressive symptoms plays reward hyposensitivity. Therefore, treatments should include evidence-based psychological interventions that target and modify reward insensitivity. Prior research lacks studies investigating reward sensitivity as main outcome measure, especially in the web-based format. This is why this study investigated an online intervention with the following groups regarding effectively increasing reward sensitivity compared to a waitlist control condition:

  1. mindfulness-based interventions, b) behavioral activation, c) a combination of both.

The daily exercises were supported via videos and worksheets. Here, the investigators explore the effects after a four-months follow-up. In addition, this paper will deal with the long-term prediction of reward sensitivity, a feature not considered in our main paper preregistered with the ID NCT05402150. Factors, which are considered to play a big role in reward sensitivity are perceived stress, depressive expectations, physical activity and the frequency of social encounters.

Being tested
Behavioral Activation, Mindfulness and Gratitude, Combination of Behavioral Activation and Mindfulness and Gratitude
Keywords
reward sensitivity, reward processing, depression, randomized controlled trial, online intervention, behavioral activation, mindfulness, gratitude
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral ActivationBehavioural

    • instruction to create a list of individual positive activities. - instruction to include daily positive activities and fill out a mood protocol, which covers the time period shortly before, during and after the activity.
  • Mindfulness and GratitudeBehavioural

    • instruction to fill out a mindfulness diary: reflection of daily pleasant situation, instructing the participants to revisit the impressions of their 5 senses during this situation, in addition they should specify how long they have actually dealt with
  • Combination of Behavioral Activation and Mindfulness and GratitudeBehavioural

    This group will do a combination of the two intervention types.

Study groups in NCT06072209
Study groupRoleWhat they receive
Behavioral ActivationExperimental14 days of daily excercises
Receives: Behavioral: Behavioral Activation
Mindfulness and GratitudeExperimental14 days of daily excercises
Receives: Behavioral: Mindfulness and Gratitude
Combination: Behavioral Activation and Mindfulness and GratitudeExperimental14 days of daily excercises
Receives: Behavioral: Combination of Behavioral Activation and Mindfulness and Gratitude
Waitlist control groupNo interventionWill receive the intervention (combination) after two weeks of intervention time of the other groups.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depressive symptoms (Patient Health Questionnaire-9, PHQ-9)

    • Items range from 0 to 3 (0 = not at all; 1 = several days; 2 = more than a week; 3 = nearly every day).
    • PHQ-9 total score ranges from 0 to 27 (classification of scores: 5-9 mild depression; 10-14 as moderate depression; 15-19: moderately severe depression; 20 - 27 severe depression).
    • Consequently, a higher score means worse depressive symptoms.

    Measured: baseline, post intervention (after 2 weeks), 4 months follow-up

  2. Reward sensitivity (Positive Valence System Scale-21, PVSS-21)

    • Items range from 1 to 9 (1 = extremely untrue of me, 2 = very untrue of me, 3 = moderately untrue of me, 4 = slightly untrue of me, 5 = neutral, 6 = slightly true of me, 7 = moderately true of me, 8 = very true of me, 9 = extremely true of me).
    • PVSS-21 total score ranges from 21 to 189.
    • Consequently, a higher score means a higher reward responding.

    Measured: baseline, post intervention (after 2 weeks), 4 months follow-up

  3. Anhedonia (Snaith-Hamilton-Pleasure-Scale, SHAPS-D)

    • Items range from "Definitely Agree", "Agree", "Disagree", and "Strongly Disagree". Either of the "Disagree responses" receive a score of 1 and either of the "Agree responses" receive a score of 0.
    • SHAPS-D total score ranges from 0 to 14.
    • Consequently, a higher score means a greater state anhedonia.

    Measured: baseline, post intervention (after 2 weeks), 4 months follow-up

  4. Change in Stress level (Perceived-Stress-Scale 10, PSS-10)

    • Items range from 1 to 5 (1= never, 2 = almost never, 3 = sometimes, 4 = fairly often, 5 = very often) Items 4, 5, 7 and 8 are reverse scored for the total score.
    • PH=perceived helplessness subscale; PSE=perceived self-efficacy subscale
    • PH subscale is computed by summing up Items 1, 2, 3, 6, 9 and 10; the PSE subscale is computed by summing up items 4, 5, 7 and 8
    • PSS-10 total score is the sum of all PH and reversed PSE items
    • Consequently, a higher score means a greater level of stress.

    Measured: baseline, post intervention (after 2 weeks), 4 months follow-up

  5. Change in Depressive Expectations (Depressive Expectations Scale, DES)

    • Items range from 1 to 5 (1 = I disagree , 2 = I partially disagree, 3 = neutral, 4 = I partially agree, 5 = I agree).
    • DES total score ranges from 25 to 125
    • Consequently, a higher score means more dysfunctional depressive expectations.

    Measured: baseline, post intervention (after 2 weeks), 4 months follow-up

  6. Amount of physical activity reported during intervention exercises

    • Type of activities and reflected pleasant situations that have been selected in the daily online surveys

    Measured: during intervention

  7. Amount of social encounters reported during intervention exercises

    • Type of activities and reflected pleasant situations that have been selected in the daily online surveys

    Measured: during intervention

Secondary outcomes (5)
  1. Personality traits (Big Five Inventory 10, BFI-10)

    • Items range from 1 (disagree strongly) to 5 (agree strongly).
    • Scales: openness to experience, conscientiousness, extraversion, agreeableness and neuroticism

    Measured: Baseline, post intervention (after 2 weeks), four months follow-up]

  2. Adherence

    • Number of completed online surveys regarding the intervention exercises (T1 to T14: daily online surveys over the course of two weeks)
    • Self report of implementation of daily exercises in post intervention survey and follow up survey.

    Measured: post intervention (after 2 weeks), 4 months follow-up

  3. Treatment expectation (Generic Rating for Treatment Pre-Experiences, Treatment Expectations, and Treatment Effects, G-EEE)

    • Items range from 0 to 10 (depending on the item from "no improvement" to "greatest improvement imaginable", from "no worsening" to "greatest worsening imaginable", from "no complaints" to "greatest complaints imaginable") and one item, where previous treatment experience is assessed via a choice of "I have never experienced this treatment." (continue with question 8), "I have experienced this treatment during the last 12 months (nearly) daily.", "I have experienced this treatment during the last 12 months on more than 10 days.", "I have experienced this treatment during the last 12 months on about 5 to 10 days.", I have experienced this treatment during the last 12 months on about 1 to 4 days." And "I have not experienced this treatment during the last 12 months, but I have experienced it before."

    Measured: Baseline, post intervention (after 2 weeks), 4 months follow-up

  4. Treatment credibility and expectancy (Credibility/Expectancy Questionnaire, CEQ)

    • Items range from 1 to 9 (Item 1 of Set 1: 1= not at all logical, 5 = somewhat logical, 9 = very logical, Item 2 of Set 1: 1= not at all useful, 5 = somewhat useful, 9 = very useful, Item 3 of Set 1: 1 = not at all confident, 5 = somewhat confident, 9 = very confident, Item 1 of Set 2: 1 = not at all, 5 = somewhat, 9 = very much), Item 4 of Set 1 and Item 2 of Set 2 give a choice of 0% to 100% in steps of 10 %.
    • CEQ composite score can be derived for each factor (expectancy and credibility)

    Measured: Baseline

  5. Trait reward responsiveness (Reward Responsiveness Scale, RRS)

    • Items range from 1 to 4 (1= strong disagreement, 2 = mild disagreement, 3 = mild agreement, 4 = strong agreement)
    • RRS total score ranges from 8 to 32.
    • Consequently, a higher score means a higher reward responsiveness.

    Measured: Baseline, post intervention (after 2 weeks), 4 months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2023
  2. Study start30 May 2022
  3. Primary completion15 May 2023
  4. Study completion15 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Participant
Enrolment
224 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06072209
Sponsor's protocol ID
ReSet your Mind - Mechanisms
Status last verified
Oct 2023
First submitted
2 Oct 2023
Last updated
12 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral Activation, Mindfulness and Gratitude and Combination of Behavioral Activation and Mindfulness and Gratitude in people with Depression Mild and Depression Moderate, run by Philipps University Marburg at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depressive symptoms (Patient Health Questionnaire-9, PHQ-9) (time frame: baseline, post intervention (after 2 weeks), 4 months follow-up). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in